CPIX
Cumberland Pharmaceuticals Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.79
+0.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.83x
- Price / sales
- 3.25x
- Price / cash flow
- 136.38x
Enterprise value
- Enterprise value
- $102.3M
- EV / sales
- 3.27x
- EV / EBITDA
- -18.11x
- EV / EBIT
- -10.62x
- Market cap
- $101.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026